🔎 Trials Near Me

Home › Lupus Nephritis › Texas › Houston

Lupus Nephritis clinical trials in Houston, TX

8 studies for Lupus Nephritis are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

RecruitingPhase 2
  • Baylor College of Medicine Pediatric Immunology Allergy Rheumatology, Houston
Ages 8 to 20 · All sexes · Updated Sep 14, 2026 · NCT05538208

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

RecruitingPhase 1
  • Baylor College of Medicine, Houston
Ages 18 to 60 · All sexes · Updated Sep 14, 2026 · NCT06975787

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

RecruitingPhase 1/2
  • University of Texas MD Anderson Cancer Center, Houston
Ages 18 to 65 · All sexes · Updated Aug 26, 2026 · NCT06121297

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

RecruitingPhase 4
  • Northwest Houston Arthritis Center, Houston
  • Novel Research LLC, Bellaire · 7 mi away
Ages 18 to 75 · All sexes · Updated Aug 3, 2026 · NCT07611214

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

RecruitingPhase 2
  • Prolato Clinical Research Center, Houston
Ages 18 to 100 · All sexes · Updated Jul 30, 2026 · NCT05268289

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

RecruitingPhase 3
  • Novel Research, LLC., Houston
  • Northwest Houston Arthritis, Houston
  • Rheumatology Care Center, PLLC, Bellaire · 7 mi away
Ages 18 to 75 · All sexes · Updated Jul 30, 2026 · NCT07201129

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

RecruitingPhase 1/2
  • Nkarta Investigational Site, Houston
Ages 18 to 75 · All sexes · Updated Jun 4, 2026 · NCT06557265

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

RecruitingPhase 1/2
  • MD Anderson Cancer Center, Houston
  • The University of Texas Health Science Center at Houston, Houston
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06434363

Lupus Nephritis trials in other cities

Other studies in Houston

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.